Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
iShares US Real Estate ETF
IYR
|
+$1B |
| 2 |
Tesla
TSLA
|
+$697M |
| 3 |
Microsoft
MSFT
|
+$447M |
| 4 |
Accenture
ACN
|
+$439M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$421M |
Top Sells
| 1 |
CRH
CRH
|
+$2.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.01B |
| 3 |
Texas Instruments
TXN
|
+$1.97B |
| 4 |
Starbucks
SBUX
|
+$1.61B |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$1.07B |
Sector Composition
| 1 | Technology | 32.41% |
| 2 | Financials | 11.84% |
| 3 | Consumer Discretionary | 10.72% |
| 4 | Healthcare | 9.02% |
| 5 | Communication Services | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Chart Industries, Inc. Depositary Shares, each Representing a 1/20th Interest in a Share of 6.75% Series B Mandatory Convertible Preferred Stock
GTLS.PRB
$572M
| $7.58M | ﹤0.01% |
150,826
-54,204
| -26% | -$2.72M |
|
1202
NOV
NOV
$4.94B
| $7.56M | ﹤0.01% |
473,545
+258,392
| +120% | +$4.13M |
|
1203
Rentokil
RTO
$12.9B
| $7.55M | ﹤0.01% |
+303,000
| New | +$7.55M |
|
1204
The Bancorp
TBBK
$3.53B
| $7.54M | ﹤0.01% |
140,844
+35,777
| +34% | +$1.91M |
|
1205
EchoStar
SATS
$22.2B
| $7.53M | ﹤0.01% |
303,399
+12,990
| +4% | +$322K |
|
1206
ADT
ADT
$7.26B
| $7.53M | ﹤0.01% |
1,041,342
-135,736
| -12% | -$981K |
|
1207
H.B. Fuller
FUL
$3.33B
| $7.5M | ﹤0.01% |
94,441
+40,571
| +75% | +$3.22M |
|
1208
Denali Therapeutics
DNLI
$2.14B
| $7.45M | ﹤0.01% |
255,883
+128,823
| +101% | +$3.75M |
|
1209
Nexstar Media Group
NXST
$5.98B
| $7.45M | ﹤0.01% |
45,051
+6,475
| +17% | +$1.07M |
|
1210
Dyne Therapeutics
DYN
$1.89B
| $7.45M | ﹤0.01% |
207,309
+128,246
| +162% | +$4.61M |
|
1211
TTM Technologies
TTMI
$4.99B
| $7.44M | ﹤0.01% |
407,524
+152,456
| +60% | +$2.78M |
|
1212
Paylocity
PCTY
$9.48B
| $7.41M | ﹤0.01% |
44,897
+5,609
| +14% | +$925K |
|
1213
Performance Food Group
PFGC
$16.3B
| $7.39M | ﹤0.01% |
94,321
-30,119
| -24% | -$2.36M |
|
1214
Credo Technology Group
CRDO
$27.6B
| $7.39M | ﹤0.01% |
239,962
-111,702
| -32% | -$3.44M |
|
1215
Apellis Pharmaceuticals
APLS
$3.29B
| $7.38M | ﹤0.01% |
255,897
+39,019
| +18% | +$1.13M |
|
1216
Cavco Industries
CVCO
$4.28B
| $7.38M | ﹤0.01% |
17,234
+10,656
| +162% | +$4.56M |
|
1217
PotlatchDeltic
PCH
$3.21B
| $7.38M | ﹤0.01% |
163,784
+97,655
| +148% | +$4.4M |
|
1218
Cactus
WHD
$2.86B
| $7.37M | ﹤0.01% |
123,562
+100,223
| +429% | +$5.98M |
|
1219
Spire
SR
$4.5B
| $7.36M | ﹤0.01% |
109,372
+61,357
| +128% | +$4.13M |
|
1220
Interactive Brokers
IBKR
$28.2B
| $7.35M | ﹤0.01% |
211,036
+85,572
| +68% | +$2.98M |
|
1221
SiriusXM
SIRI
$8.02B
| $7.35M | ﹤0.01% |
310,684
+287,102
| +1,217% | +$6.79M |
|
1222
First Industrial Realty Trust
FR
$6.77B
| $7.34M | ﹤0.01% |
131,111
+33,702
| +35% | +$1.89M |
|
1223
Aramark
ARMK
$10B
| $7.34M | ﹤0.01% |
189,418
+69,223
| +58% | +$2.68M |
|
1224
Shake Shack
SHAK
$3.92B
| $7.33M | ﹤0.01% |
71,027
-28,218
| -28% | -$2.91M |
|
1225
Royal Gold
RGLD
$12.3B
| $7.33M | ﹤0.01% |
52,252
-5,683
| -10% | -$797K |
|